Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 34 M41 M38 M511 M24 M98 M 671 M Research & development —————— — Operating income -106 M66 M263 M-313 M210 M-72 M 88 M Non-Operating Income, Total -285 M291 M188 M12 M-458 M-2 M -260 M Interest expense, net of interest capitalized 1 M1 M02 M—— — Non-Operating Income, excl. Interest Expenses -289 M286 M186 M20 M-470 M-25 M -289 M Unusual income/expense 3 M4 M2 M-10 M12 M23 M 27 M Pretax income -187 M97 M304 M-380 M81 M-129 M -124 M Equity in earnings —————— — Taxes -52 M25 M97 M-17 M18 M-37 M 61 M Non-controlling/minority interest 0000—— — After tax other income/expense -37 M-8 M-73 M29 M-4 M-31 M -79 M Net income before discontinued operations -135 M72 M207 M-363 M63 M-92 M -185 M Discontinued operations —————— — Net income -135 M72 M207 M-363 M63 M-92 M -185 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -135 M72 M207 M-363 M63 M-92 M -185 M Basic earnings per share (Basic EPS) -2.941.584.52-7.951.38-2 -4.05 Diluted earnings per share (Diluted EPS) -2.941.54.25-7.61.33-2 -4.02 Average basic shares outstanding 45.85 M45.55 M45.68 M45.69 M45.61 M45.9 M — Diluted shares outstanding 45.85 M47.91 M48.58 M45.69 M47.43 M45.9 M — EBITDA 658 M845 M897 M289 M723 M567 M 2.48 B EBIT 54 M775 M836 M215 M631 M464 M 2.15 B Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 74 M70 M61 M74 M92 M103 M 330 M